Across TCGA pan-cancer cohorts, RPSAP33 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RPSAP33 data layer.
The strongest signal is observed in kidney chromophobe (KICH), where higher RPSAP33 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPSAP33 expression acts as an unfavorable survival marker, although some lineages such as COAD and BRCA show a favorable association.
KICH, MESO, and LIHC are the cancer types where RPSAP33 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.